Upon chemical and irradiation exposure, surviving cancer cells produce pro-tumor cytokines as IL-17, stromal cell-derived factor-1 (SDF-1), CCL2, and colony-stimulating factor 1 (CSF-1), which limit the therapeutic benefits [44,163,164,165]. Here, CCL2 is linked to neoplasm.